Medicover AB

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: SE0009778848
SEK
231.00
-2 (-0.86%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryPrice Point
High/Low

1Day

52 Week

Valuation
Technical
Day's Volume

CASH

68.12 k

Shareholding (Jun 2024)

FII

0.18%

Held by 1 FIIs

DII

99.82%

Held by 0 DIIs

Promoter

0.00%

iScoreScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.

Dashboard
1

Healthy long term growth as Net Sales has grown by an annual rate of 21.47%

 
2

With a growth in Net Profit of 188.7%, the company declared Very Positive results in Jun 25

3

With ROE of 12.45%, it has a fair valuation with a 7.38 Price to Book Value

4

Market Beating Performance

stock-summaryMojo Parameters
Mojo Parameters
Stock DNA
stock-summary
Industry

Pharmaceuticals & Biotechnology

stock-summary
Market cap

SEK 17,808 Million (Small Cap)

stock-summary
P/E

59.00

stock-summary
Industry P/E

NA

stock-summary
Dividend Yield

0.06%

stock-summary
Debt Equity

1.68

stock-summary
Return on Equity

12.96%

stock-summary
Price to Book

3.17

Revenue and Profits:
Net Sales:
6,539 Million
(Quarterly Results - Jun 2025)
Net Profit:
197 Million
stock-summaryTotal Returns
Total Returns (Price + Dividend) stock-summary
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
-11.32%
0%
-11.32%
6 Months
-3.95%
0%
-3.95%
1 Year
27.62%
0%
27.62%
2 Years
61.31%
0%
61.31%
3 Years
66.91%
0%
66.91%
4 Years
-17.5%
0%
-17.5%
5 Years
67.39%
0%
67.39%

Medicover AB for the last several years.

Risk Adjusted Returns v/s stock-summary
stock-summaryNews & Corporate Actions
News
Icon
No Recent News for the Company
Announcements stock-summary
Icon
No announcement available
Corporate Actions stock-summary
Icon
No corporate action available
stock-summaryKey Factors
Quality key factors stock-summary
Factor
Value
Sales Growth (5y)
21.47%
EBIT Growth (5y)
29.36%
EBIT to Interest (avg)
3.30
Debt to EBITDA (avg)
1.57
Net Debt to Equity (avg)
1.35
Sales to Capital Employed (avg)
1.64
Tax Ratio
28.27%
Dividend Payout Ratio
129.11%
Pledged Shares
0
Institutional Holding
0.18%
ROCE (avg)
11.54%
ROE (avg)
9.18%
Valuation key factors
Factor
Value
P/E Ratio
59
Industry P/E
Price to Book Value
7.38
EV to EBIT
33.60
EV to EBITDA
12.22
EV to Capital Employed
3.25
EV to Sales
1.89
PEG Ratio
0.39
Dividend Yield
0.03%
ROCE (Latest)
9.68%
ROE (Latest)
12.45%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Bearish
Bullish
RSI
No Signal
No Signal
Bollinger Bands
Bearish
Mildly Bullish
Moving Averages
Mildly Bullish (Daily)
KST
Bearish
Bullish
Dow Theory
Mildly Bearish
No Trend
OBV
Mildly Bearish
No Trend
stock-summary Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
stock-summaryShareholding
Shareholding Snapshot : Jun 2024stock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Foreign Institutions

Domestic Funds

Held in 0 Schemes (0%)

Foreign Institutions

Held by 1 Foreign Institutions (0.18%)

Strategic Entities with highest holding

Highest Public shareholder

stock-summaryFinancial
[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Jun'25 - YoY",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in quarter ended Jun 2025 is 11.55% vs 20.31% in Jun 2024",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in quarter ended Jun 2025 is 190.57% vs -17.80% in Jun 2024",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Jun'25",
        "Jun'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "6,539.00",
          "val2": "5,862.10",
          "chgp": "11.55%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "1,066.30",
          "val2": "821.70",
          "chgp": "29.77%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "180.80",
          "val2": "162.30",
          "chgp": "11.40%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "-12.10",
          "val2": "-9.20",
          "chgp": "-31.52%",
          "chgp_class": "negative"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "197.30",
          "val2": "67.90",
          "chgp": "190.57%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "71.70%",
          "val2": "43.40%",
          "chgp": "2.83%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Dec'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Dec 2024 is 19.35% vs 24.79% in Dec 2023",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Dec 2024 is -20.93% vs 44.96% in Dec 2023",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Dec'24",
        "Dec'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "23,922.70",
          "val2": "20,043.50",
          "chgp": "19.35%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "3,291.40",
          "val2": "2,810.70",
          "chgp": "17.10%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "672.50",
          "val2": "589.90",
          "chgp": "14.00%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "-220.70",
          "val2": "-10.30",
          "chgp": "-2,042.72%",
          "chgp_class": "negative"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "167.00",
          "val2": "211.20",
          "chgp": "-20.93%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "42.80%",
          "val2": "35.70%",
          "chgp": "0.71%",
          "chgp_class": "positive"
        }
      ]
    }
  }
]
Quarterly Results Snapshot (Consolidated) - Jun'25 - YoYstock-summary
Jun'25
Jun'24
Change(%)
Net Sales
6,539.00
5,862.10
11.55%
Operating Profit (PBDIT) excl Other Income
1,066.30
821.70
29.77%
Interest
180.80
162.30
11.40%
Exceptional Items
-12.10
-9.20
-31.52%
Consolidate Net Profit
197.30
67.90
190.57%
Operating Profit Margin (Excl OI)
71.70%
43.40%
2.83%
USD in Million.
Direction Arrows
Net Sales

YoY Growth in quarter ended Jun 2025 is 11.55% vs 20.31% in Jun 2024

Direction Arrows
Consolidated Net Profit

YoY Growth in quarter ended Jun 2025 is 190.57% vs -17.80% in Jun 2024

Annual Results Snapshot (Consolidated) - Dec'24stock-summary
Dec'24
Dec'23
Change(%)
Net Sales
23,922.70
20,043.50
19.35%
Operating Profit (PBDIT) excl Other Income
3,291.40
2,810.70
17.10%
Interest
672.50
589.90
14.00%
Exceptional Items
-220.70
-10.30
-2,042.72%
Consolidate Net Profit
167.00
211.20
-20.93%
Operating Profit Margin (Excl OI)
42.80%
35.70%
0.71%
USD in Million.
Direction Arrows
Net Sales

YoY Growth in year ended Dec 2024 is 19.35% vs 24.79% in Dec 2023

Direction Arrows
Consolidated Net Profit

YoY Growth in year ended Dec 2024 is -20.93% vs 44.96% in Dec 2023

stock-summaryCompany CV
About Medicover AB stock-summary
stock-summary
Medicover AB
Pharmaceuticals & Biotechnology
Medicover AB is a Sweden-based healthcare and diagnostic services provider. It offers a broad range of healthcare services and hub-and-spoke diagnostic laboratory network, supported by proprietary software and information systems infrastructure. The Company offers its services through two divisions: Healthcare Services and Diagnostic Services. The Healthcare Services division offers services ranging from primary care to specialist outpatient and inpatient care. The care is delivered mainly through Medicover’s own network of clinics and medical facilities. The Diagnostic Services division offers a broad range of diagnostic laboratory testing for humans and some veterinary services across all main clinical pathology specialties. The Company focuses primarily on such markets, as Poland, Germany, Romania, Ukraine.
Company Coordinates stock-summary
Company Details
Riddargatan 12 3Tr , STOCKHOLM None : 114 35
stock-summary
Tel: 46 8 4001760046 8 40017606
stock-summary
Registrar Details